AskTheDate.com
Back to calendar

Spyre Therapeutics, Inc. (SYRE) Earnings

SYRE reports earnings on Tuesday, November 3, 2026

earnings report
November 3, 2026 · After Market Close
Q3 2026
Est. EPS: $-1.00
Actual EPS: $-0.94
EPS surprise: -14.32%
Company overview
Market Cap$9.1B
PriceUSD 99.04
EPS (TTM)-3.08
52-week high110.17
52-week low21.14
SectorHealth Technology
IndustryPharmaceuticals: Major
Employees102
Buy me a coffee